Report Detail

Request for Sample of this report

Other Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contraceptives Drugs and Devices Market 2018, Forecast to 2023

  • RnM2718963
    • |
  • 03 January, 2019
    • |
  • Global
    • |
  • 132 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.

Scope of the Report:
This report focuses on the Contraceptives Drugs and Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Contraceptives Drugs and Devices is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 30100 million US$ in 2023, from 19000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

Market Segment by Applications, can be divided into
Female
Male

There are 15 Chapters to deeply display the global Contraceptives Drugs and Devices market.
Chapter 1, to describe Contraceptives Drugs and Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Contraceptives Drugs and Devices, with sales, revenue, and price of Contraceptives Drugs and Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Contraceptives Drugs and Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Contraceptives Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Contraceptives Drugs and Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Contraceptives Drugs and Devices Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
      • 1.2.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
    • 1.3 Market Analysis by Applications
      • 1.3.1 Female
      • 1.3.2 Male
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Teva Pharmaceutical Industries Ltd
      • 2.1.1 Business Overview
        • 2.1.1.1 Teva Pharmaceutical Industries Ltd Description
        • 2.1.1.2 Teva Pharmaceutical Industries Ltd Headquarter, Main Business and Finance Overview
      • 2.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Introduction
        • 2.1.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.1.2.2 Contraceptives Drugs and Devices Product Information
      • 2.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.1 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.2 Global Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Market Share in 2017
    • 2.2 Church & Dwight Co. Inc
      • 2.2.1 Business Overview
        • 2.2.1.1 Church & Dwight Co. Inc Description
        • 2.2.1.2 Church & Dwight Co. Inc Headquarter, Main Business and Finance Overview
      • 2.2.2 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Introduction
        • 2.2.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.2.2.2 Contraceptives Drugs and Devices Product Information
      • 2.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.1 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.2 Global Church & Dwight Co. Inc Contraceptives Drugs and Devices Market Share in 2017
    • 2.3 Reckitt Benckiser Plc
      • 2.3.1 Business Overview
        • 2.3.1.1 Reckitt Benckiser Plc Description
        • 2.3.1.2 Reckitt Benckiser Plc Headquarter, Main Business and Finance Overview
      • 2.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Introduction
        • 2.3.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.3.2.2 Contraceptives Drugs and Devices Product Information
      • 2.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.1 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.2 Global Reckitt Benckiser Plc Contraceptives Drugs and Devices Market Share in 2017
    • 2.4 Pfizer, Inc
      • 2.4.1 Business Overview
        • 2.4.1.1 Pfizer, Inc Description
        • 2.4.1.2 Pfizer, Inc Headquarter, Main Business and Finance Overview
      • 2.4.2 Pfizer, Inc Contraceptives Drugs and Devices Product Introduction
        • 2.4.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.4.2.2 Contraceptives Drugs and Devices Product Information
      • 2.4.3 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.1 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.2 Global Pfizer, Inc Contraceptives Drugs and Devices Market Share in 2017
    • 2.5 Bayer AG
      • 2.5.1 Business Overview
        • 2.5.1.1 Bayer AG Description
        • 2.5.1.2 Bayer AG Headquarter, Main Business and Finance Overview
      • 2.5.2 Bayer AG Contraceptives Drugs and Devices Product Introduction
        • 2.5.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.5.2.2 Contraceptives Drugs and Devices Product Information
      • 2.5.3 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.1 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.2 Global Bayer AG Contraceptives Drugs and Devices Market Share in 2017
    • 2.6 Mayer Laboratories, Inc
      • 2.6.1 Business Overview
        • 2.6.1.1 Mayer Laboratories, Inc Description
        • 2.6.1.2 Mayer Laboratories, Inc Headquarter, Main Business and Finance Overview
      • 2.6.2 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Introduction
        • 2.6.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.6.2.2 Contraceptives Drugs and Devices Product Information
      • 2.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.1 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.2 Global Mayer Laboratories, Inc Contraceptives Drugs and Devices Market Share in 2017
    • 2.7 The Female Health Company
      • 2.7.1 Business Overview
        • 2.7.1.1 The Female Health Company Description
        • 2.7.1.2 The Female Health Company Headquarter, Main Business and Finance Overview
      • 2.7.2 The Female Health Company Contraceptives Drugs and Devices Product Introduction
        • 2.7.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.7.2.2 Contraceptives Drugs and Devices Product Information
      • 2.7.3 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.1 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.2 Global The Female Health Company Contraceptives Drugs and Devices Market Share in 2017
    • 2.8 Cooper Surgical, Inc
      • 2.8.1 Business Overview
        • 2.8.1.1 Cooper Surgical, Inc Description
        • 2.8.1.2 Cooper Surgical, Inc Headquarter, Main Business and Finance Overview
      • 2.8.2 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Introduction
        • 2.8.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.8.2.2 Contraceptives Drugs and Devices Product Information
      • 2.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.1 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.2 Global Cooper Surgical, Inc Contraceptives Drugs and Devices Market Share in 2017
    • 2.9 Allergan plc
      • 2.9.1 Business Overview
        • 2.9.1.1 Allergan plc Description
        • 2.9.1.2 Allergan plc Headquarter, Main Business and Finance Overview
      • 2.9.2 Allergan plc Contraceptives Drugs and Devices Product Introduction
        • 2.9.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.9.2.2 Contraceptives Drugs and Devices Product Information
      • 2.9.3 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.1 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.2 Global Allergan plc Contraceptives Drugs and Devices Market Share in 2017
    • 2.10 Cipla Limited
      • 2.10.1 Business Overview
        • 2.10.1.1 Cipla Limited Description
        • 2.10.1.2 Cipla Limited Headquarter, Main Business and Finance Overview
      • 2.10.2 Cipla Limited Contraceptives Drugs and Devices Product Introduction
        • 2.10.2.1 Contraceptives Drugs and Devices Production Bases, Sales Regions and Major Competitors
        • 2.10.2.2 Contraceptives Drugs and Devices Product Information
      • 2.10.3 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.1 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.2 Global Cipla Limited Contraceptives Drugs and Devices Market Share in 2017
    • 2.11 Merck & Co. Inc
      • 2.11.1 Business Overview
      • 2.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Product Introduction
      • 2.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Contraceptives Drugs and Devices Market Competition, by Manufacturer

    • 3.1 Global Contraceptives Drugs and Devices Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Global Contraceptives Drugs and Devices Price by Manufacturer (2016-2017)
    • 3.4 Market Concentration Rate
      • 3.4.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
      • 3.4.2 Top 5 Contraceptives Drugs and Devices Manufacturer Market Share in 2017
    • 3.5 Market Competition Trend

    4 Global Contraceptives Drugs and Devices Market Analysis by Regions

    • 4.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Contraceptives Drugs and Devices Sales by Regions (2013-2018)
      • 4.1.2 Global Contraceptives Drugs and Devices Revenue by Regions (2013-2018)
    • 4.2 North America Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
    • 4.3 Europe Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
    • 4.5 South America Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2013-2018)

    5 North America Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers

    • 5.1 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Contraceptives Drugs and Devices Sales by Countries (2013-2018)
      • 5.1.2 North America Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
      • 5.1.3 United States Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 5.1.4 Canada Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 5.1.5 Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
    • 5.2 North America Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 5.2.1 North America Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
      • 5.2.2 North America Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
    • 5.3 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 5.3.1 North America Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
      • 5.3.2 North America Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
    • 5.4 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
      • 5.4.1 North America Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
      • 5.4.2 North America Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)

    6 Europe Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers

    • 6.1 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Contraceptives Drugs and Devices Sales by Countries (2013-2018)
      • 6.1.2 Europe Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
      • 6.1.3 Germany Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 6.1.4 UK Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 6.1.5 France Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 6.1.6 Russia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 6.1.7 Italy Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
    • 6.2 Europe Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 6.2.1 Europe Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
      • 6.2.2 Europe Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
    • 6.3 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 6.3.1 Europe Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
      • 6.3.2 Europe Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
    • 6.4 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
      • 6.4.1 Europe Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
      • 6.4.2 Europe Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)

    7 Asia-Pacific Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers

    • 7.1 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Contraceptives Drugs and Devices Sales by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
      • 7.1.3 China Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 7.1.4 Japan Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 7.1.5 Korea Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 7.1.6 India Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 7.1.7 Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
    • 7.2 Asia-Pacific Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 7.2.1 Asia-Pacific Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
      • 7.2.2 Asia-Pacific Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
    • 7.3 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 7.3.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
      • 7.3.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
    • 7.4 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
      • 7.4.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
      • 7.4.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)

    8 South America Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers

    • 8.1 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Contraceptives Drugs and Devices Sales by Countries (2013-2018)
      • 8.1.2 South America Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
      • 8.1.3 Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 8.1.4 Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 8.1.5 Colombia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
    • 8.2 South America Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 8.2.1 South America Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
      • 8.2.2 South America Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
    • 8.3 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 8.3.1 South America Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
      • 8.3.2 South America Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
    • 8.4 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
      • 8.4.1 South America Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
      • 8.4.2 South America Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)

    9 Middle East and Africa Contraceptives Drugs and Devices by Countries, Type, Application and Manufacturers

    • 9.1 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Countries (2013-2018)
      • 9.1.3 Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 9.1.4 UAE Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 9.1.5 Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 9.1.6 Nigeria Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
      • 9.1.7 South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2013-2018)
    • 9.2 Middle East and Africa Contraceptives Drugs and Devices Sales and Revenue (Value) by Manufacturers (2016-2017)
      • 9.2.1 Middle East and Africa Contraceptives Drugs and Devices Sales by Manufacturers (2016-2017)
      • 9.2.2 Middle East and Africa Contraceptives Drugs and Devices Revenue by Manufacturers (2016-2017)
    • 9.3 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 9.3.1 Middle East and Africa Contraceptives Drugs and Devices Sales and Sales Share by Type (2013-2018)
      • 9.3.1 Middle East and Africa Contraceptives Drugs and Devices Revenue and Revenue Share by Type (2013-2018)
    • 9.4 Middle East and Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Application (2013-2018)
      • 9.4.1 Middle East and Africa Contraceptives Drugs and Devices Sales and Sales Share by Application (2013-2018)
      • 9.4.2 Middle East and Africa Contraceptives Drugs and Devices Revenue and Revenue Share by Application (2013-2018)

    10 Global Contraceptives Drugs and Devices Market Segment by Type

    • 10.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2013-2018)
    • 10.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth and Price
      • 10.2.1 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Sales Growth (2013-2018)
      • 10.2.2 Global Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Price (2013-2018)
    • 10.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth and Price
      • 10.3.1 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Sales Growth (2013-2018)
      • 10.3.2 Global Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Price (2013-2018)

    11 Global Contraceptives Drugs and Devices Market Segment by Application

    • 11.1 Global Contraceptives Drugs and Devices Sales Market Share by Application (2013-2018)
    • 11.2 Female Sales Growth (2013-2018)
    • 11.3 Male Sales Growth (2013-2018)

    12 Contraceptives Drugs and Devices Market Forecast (2018-2023)

    • 12.1 Global Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Contraceptives Drugs and Devices Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Contraceptives Drugs and Devices Market Forecast (2018-2023)
      • 12.2.2 Europe Contraceptives Drugs and Devices Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Contraceptives Drugs and Devices Market Forecast (2018-2023)
      • 12.2.4 South America Contraceptives Drugs and Devices Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Contraceptives Drugs and Devices Market Forecast (2018-2023)
    • 12.3 Contraceptives Drugs and Devices Market Forecast by Type (2018-2023)
      • 12.3.1 Global Contraceptives Drugs and Devices Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Contraceptives Drugs and Devices Market Share Forecast by Type (2018-2023)
    • 12.4 Contraceptives Drugs and Devices Market Forecast by Application (2018-2023)
      • 12.4.1 Global Contraceptives Drugs and Devices Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Contraceptives Drugs and Devices Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Contraceptives Drugs and Devices . Industry analysis & Market Report on Contraceptives Drugs and Devices is a syndicated market report, published as Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Contraceptives Drugs and Devices Market 2018, Forecast to 2023. It is complete Research Study and Industry Analysis of Contraceptives Drugs and Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$4,880.00
      		$7,320.00
      		$9,760.00
      		3,845.44
      		5,768.16
      		7,690.88
      		4,489.60
      		6,734.40
      		8,979.20
      		760,255.20
      		1,140,382.80
      		1,520,510.40
      		406,796.80
      		610,195.20
      		813,593.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo